SK8882002A3 - Human heparanase-related polypeptide and nucleic acid - Google Patents

Human heparanase-related polypeptide and nucleic acid Download PDF

Info

Publication number
SK8882002A3
SK8882002A3 SK888-2002A SK8882002A SK8882002A3 SK 8882002 A3 SK8882002 A3 SK 8882002A3 SK 8882002 A SK8882002 A SK 8882002A SK 8882002 A3 SK8882002 A3 SK 8882002A3
Authority
SK
Slovakia
Prior art keywords
polypeptide
polynucleotide
diseases
sequence
expression
Prior art date
Application number
SK888-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Gerhard Siemeister
Bertram Weiss
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK8882002A3 publication Critical patent/SK8882002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01139—Alpha-glucuronidase (3.2.1.139)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK888-2002A 1999-12-23 2000-12-18 Human heparanase-related polypeptide and nucleic acid SK8882002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125831 1999-12-23
PCT/EP2000/012909 WO2001048161A2 (en) 1999-12-23 2000-12-18 Human heparanase-related polypeptide and nucleic acid

Publications (1)

Publication Number Publication Date
SK8882002A3 true SK8882002A3 (en) 2002-11-06

Family

ID=8239724

Family Applications (1)

Application Number Title Priority Date Filing Date
SK888-2002A SK8882002A3 (en) 1999-12-23 2000-12-18 Human heparanase-related polypeptide and nucleic acid

Country Status (20)

Country Link
US (1) US20040161745A1 (bg)
EP (1) EP1244778A2 (bg)
JP (1) JP2003518381A (bg)
KR (1) KR20020062375A (bg)
CN (1) CN1413249A (bg)
AU (1) AU3013901A (bg)
BG (1) BG106842A (bg)
BR (1) BR0016703A (bg)
CA (1) CA2392703A1 (bg)
CZ (1) CZ20022147A3 (bg)
EE (1) EE200200353A (bg)
HU (1) HUP0203724A2 (bg)
IL (1) IL149506A0 (bg)
MX (1) MXPA02005077A (bg)
NO (1) NO20023015D0 (bg)
PL (1) PL362867A1 (bg)
RU (1) RU2002119561A (bg)
SK (1) SK8882002A3 (bg)
WO (1) WO2001048161A2 (bg)
ZA (1) ZA200205852B (bg)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5033101A (en) * 2000-02-24 2001-10-08 Bayer Aktiengesellschaft Regulation of human heparanase-like enzyme
GB0008912D0 (en) * 2000-04-11 2000-05-31 Janssen Pharmaceutica Nv Mammalian heparanase
EP1276862A2 (en) * 2000-04-20 2003-01-22 Pharmacia & Upjohn Company Heparanase ii, a human heparanase paralog
WO2002004645A2 (en) * 2000-07-12 2002-01-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas
FR2818131B1 (fr) * 2000-12-14 2005-02-11 Oreal Composition cosmetique comprenant de l'heparanase
CN101311188B (zh) * 2007-05-21 2010-12-29 中国人民解放军军事医学科学院生物工程研究所 人乙酰肝素酶的小分子多肽抑制剂
CN101670115B (zh) * 2009-07-31 2011-07-27 中国人民解放军第三军医大学 乙酰肝素酶与热休克蛋白的复合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
CA2307830A1 (en) * 1997-10-28 1999-05-06 The Australian National University Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
PL362599A1 (en) * 1999-06-25 2004-11-02 Insight Strategy & Marketing Ltd. Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
JP2003510053A (ja) * 1999-09-23 2003-03-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング ヘパラナーゼ蛋白質ファミリーの１種、ヘパラナーゼ−２

Also Published As

Publication number Publication date
BG106842A (bg) 2003-05-30
WO2001048161A2 (en) 2001-07-05
EE200200353A (et) 2003-10-15
CA2392703A1 (en) 2001-07-05
NO20023015L (no) 2002-06-21
ZA200205852B (en) 2003-10-22
CN1413249A (zh) 2003-04-23
IL149506A0 (en) 2002-11-10
PL362867A1 (en) 2004-11-02
NO20023015D0 (no) 2002-06-21
HUP0203724A2 (hu) 2003-03-28
BR0016703A (pt) 2002-09-24
JP2003518381A (ja) 2003-06-10
CZ20022147A3 (cs) 2002-09-11
RU2002119561A (ru) 2004-02-10
MXPA02005077A (es) 2002-11-07
US20040161745A1 (en) 2004-08-19
KR20020062375A (ko) 2002-07-25
EP1244778A2 (en) 2002-10-02
WO2001048161A3 (en) 2002-02-14
AU3013901A (en) 2001-07-09

Similar Documents

Publication Publication Date Title
US9453050B2 (en) Compositions for treating glioma
JP2002506625A (ja) サイトカインレセプター共通γ鎖様
CN101115767A (zh) 包含vWFA和/或ANT_IG结构域的蛋白质
JPWO2005097204A1 (ja) 癌の予防・治療剤
JPWO2006093337A1 (ja) 癌の予防・治療剤
JP5704722B2 (ja) 細胞接着阻害剤およびその用途
JP2007529410A (ja) 子宮内膜症を治療又は防止するためのペプチド
SK8882002A3 (en) Human heparanase-related polypeptide and nucleic acid
JPH11507513A (ja) Ｃ５ａ様７膜貫通受容体
JP2002530064A (ja) Ｅｇｆ様核酸およびポリペプチド、ならびにその使用
JPH11501817A (ja) ヒト臍静脈内皮細胞で発現されるヒアルロン酸レセプタ
JP2000515726A (ja) 分泌蛋白をコードする成人ｐｂｍｃ由来のポリヌクレオチド
JP4530631B2 (ja) 新規タンパク質および癌の予防・治療剤
JP2002527053A (ja) 骨形成蛋白質誘導性遺伝子およびポリペプチド、並びに診断および治療方法におけるそれらの使用
JPWO2005061704A1 (ja) 癌の予防・治療剤
JP2003528609A (ja) バスコスタチンおよび他のニドゲンドメインの抗血管形成特性および抗腫瘍特性
KR20050085881A (ko) 신규 단백질 및 그 용도
KR101755076B1 (ko) Ell3 단백질을 이용한 항염증제의 스크리닝 방법 및 상기 ell3 단백질의 발현 또는 활성 억제제를 포함하는 항염 조성물
JP2001029090A (ja) 新規ポリペプチド
JP2004026692A (ja) Ｍｅｐｅの新規用途
JP2001299363A (ja) 新規タンパク質およびそのｄｎａ
WO2004018678A1 (ja) 癌の予防・治療剤
JP2005151826A (ja) Ｃ１ｑｔｎｆ５の用途
JP2003532623A (ja) 抗脈管形成性アンジオテンシン−７およびそれをコードするポリヌクレオチドを使用することによる脈管形成の調節方法
JP2002355063A (ja) 新規疾患関連遺伝子およびその用途